IMS Health Holdings reported an employee base numbering more than 15,000 people at the close of 2015, up from 10,200 a year earlier as the company absorbed business units of Cegedim it acquired for $426 million last April, as well as 14 smaller companies.
Danbury-based IMS Health (NYSE: IMS) tracks pharmaceutical pricing and sales and helps drug developers improve their processes, earning $417 million last year as revenue rose 11 percent to $2.9 billion. Fourth-quarter profits tripled to $29 million or 9 cents a share, up from $8 million or 3 cents a year earlier, as sales jumped 20 percent to $812 million.
